Recently, news of a man who died after receiving six coronary stents in a single procedure has sparked widespread public concern. It’s important to clarify that percutaneous coronary intervention (PCI), commonly known as stent placement, is an effective treatment for severe coronary artery disease, angina, or heart attacks—but only when medically justified. While implanting multiple stents in one session is uncommon, it may be necessary in cases of severe blockages across several coronary arteries. However, excessive stent use can increase risks such as blood clots, bleeding, or restenosis, and may divert attention from comprehensive management of the underlying condition. This incident underscores two key points: patients should seek care at accredited medical institutions and fully understand their treatment options, while clinicians must base interventions on evidence-based guidelines to avoid unnecessary procedures. China’s National Health Commission has repeatedly emphasized the need to standardize cardiovascular interventions and prevent ‘stent overuse.’ Ultimately, all medical decisions should involve thorough doctor-patient communication and careful risk-benefit assessment to ensure patient safety and optimal outcomes.
近日，一则‘男子被一次性植入6个心脏支架后去世’的新闻引发公众广泛关注。需要明确的是，心脏支架手术（即经皮冠状动脉介入治疗，PCI）是治疗严重冠心病、心绞痛或心肌梗死的有效手段，但其使用必须严格遵循医学指征。一次性植入多个支架在临床上虽不常见，但在多支血管严重狭窄的情况下，医生可能根据患者具体情况决定植入数量。然而，过度使用支架不仅增加手术风险，如血栓形成、出血或再狭窄，还可能掩盖对基础病因的系统管理。该事件提醒我们：一方面，患者应选择正规医疗机构，充分了解治疗方案；另一方面，医疗行为需以循证医学为依据，避免不必要的干预。国家卫健委近年来也多次强调规范心血管介入诊疗行为，防止‘支架滥用’。最终，任何医疗决策都应在医患充分沟通、权衡利弊后作出，以保障患者安全与疗效。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/4640.html